2023
DOI: 10.1016/j.jns.2022.120537
|View full text |Cite
|
Sign up to set email alerts
|

Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…Notably, Plat has been extensively studied for its therapeutic potential in treating thrombotic disorders like ischemic stroke and myocardial infraction. [84][85][86][87][88] Therefore, further research is required to clarify the exact role of Plat in osteoblast differentiation and bone formation and its potential as a therapeutic target for osteoporosis and other bone-related disorders.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, Plat has been extensively studied for its therapeutic potential in treating thrombotic disorders like ischemic stroke and myocardial infraction. [84][85][86][87][88] Therefore, further research is required to clarify the exact role of Plat in osteoblast differentiation and bone formation and its potential as a therapeutic target for osteoporosis and other bone-related disorders.…”
Section: Discussionmentioning
confidence: 99%
“…These findings underscore the complex and context‐dependent roles of Plat and PAI‐1 in bone physiology and highlight the importance of investigating their regulation and interactions in osteoblast differentiation. Notably, Plat has been extensively studied for its therapeutic potential in treating thrombotic disorders like ischemic stroke and myocardial infraction 84–88 . Therefore, further research is required to clarify the exact role of Plat in osteoblast differentiation and bone formation and its potential as a therapeutic target for osteoporosis and other bone‐related disorders.…”
Section: Discussionmentioning
confidence: 99%
“…The optimal dose of TNK appears to be 0.25 mg/kg, which has been shown to have the greatest odds of achieving early neurological improvement and an excellent functional outcome at three months, with reduced odds of ICH. 3345…”
Section: Discussionmentioning
confidence: 99%
“…Several systematic reviews and meta-analyses have compared the effectiveness and safety of TNK and alteplase for treating AIS with superior and non-inferiority designs. [33][34][35][36][37][38][39][40][41][42][43][44][45] Overall, the studies suggested that TNK may be more effective than Alteplase in improving early neurological function and higher recanalization rates; there have been no significant differences between the two drugs regarding functional outcomes, disability-free three-month outcomes, or mortality. The optimal dose of TNK appears to be 0.25 mg/kg, which has been shown to have the greatest odds of achieving early neurological improvement and an excellent functional outcome at three months, with reduced odds of ICH.…”
Section: Studymentioning
confidence: 99%
See 1 more Smart Citation